Article
Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
Diagnostic microbiology and infectious disease - 1 Mar 2011
Simner Patricia J, Zhanel George G, Pitout Johann, Tailor Franil, McCracken Melissa, Mulvey Michael R, Lagacé-Wiens Philippe R S, Adam Heather J, Hoban Daryl J
Abstract excerpt
The national prevalence of extended-spectrum β-lactamase (ESBL)-producing (2007: 3.4%, 2008: 4.9%, 2009: 4.3%) and AmpC β-lactamase (AmpC)-producing (2007: 0.8%, 2008: 3.2%, 2009: 2.7%) Escherichia coli in Canadian hospitals have fluctuated from 2007 to 2009. Rates of co-resistance to non-lactam agents are elevated, and multidrug-resistant (MDR) phenotype were observed among E. coli strains producing ESBLs (83.3%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
